Target type: molecularfunction
Binding to a protein component of a cytoskeleton (actin, microtubule, or intermediate filament cytoskeleton). [GOC:mah]
Cytoskeletal protein binding is a molecular function that describes the ability of proteins to interact with components of the cytoskeleton. The cytoskeleton is a complex network of protein filaments that provides structural support, shape, and motility to cells. It is composed of three major types of filaments: microtubules, microfilaments (actin filaments), and intermediate filaments.
Cytoskeletal protein binding proteins can interact with these filaments in a variety of ways, including:
* **Direct binding:** Some proteins bind directly to the surface of cytoskeletal filaments, often through specific protein domains. For example, the motor protein kinesin binds to microtubules and uses ATP hydrolysis to move cargo along the filament.
* **Indirect binding:** Other proteins bind indirectly to cytoskeletal filaments through intermediary proteins. For example, some adaptor proteins link cytoskeletal filaments to other cellular structures, such as the plasma membrane or organelles.
* **Regulation of assembly and disassembly:** Some proteins can regulate the assembly and disassembly of cytoskeletal filaments. For example, the protein actin-depolymerizing factor (ADF) promotes the disassembly of actin filaments.
Cytoskeletal protein binding is essential for a wide range of cellular processes, including:
* **Cell shape and organization:** The cytoskeleton provides structural support to cells and helps to maintain their shape.
* **Cell motility:** The cytoskeleton is involved in cell movement, including crawling, swimming, and gliding.
* **Intracellular transport:** The cytoskeleton acts as a network of tracks for the transport of organelles, vesicles, and other cellular components.
* **Signal transduction:** The cytoskeleton can be involved in signal transduction pathways, transmitting signals from the cell surface to the interior of the cell.
The specific function of a cytoskeletal protein binding protein depends on its binding partners and its interactions with other cellular components. These interactions can be regulated by a variety of factors, including phosphorylation, ubiquitination, and other post-translational modifications.
In summary, cytoskeletal protein binding is a fundamental molecular function that plays a crucial role in a wide range of cellular processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Dual specificity protein phosphatase 3 | A dual specificity protein phosphatase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51452] | Homo sapiens (human) |
Calpain-2 catalytic subunit | A calpain-2 catalytic subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17655] | Homo sapiens (human) |
Annexin A2 | An annexin A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P07355] | Homo sapiens (human) |
Fatty acid-binding protein, heart | A fatty acid-binding protein, heart that is encoded in the genome of human. [PRO:DNx, UniProtKB:P05413] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
celecoxib | organofluorine compound; pyrazoles; sulfonamide; toluenes | cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug | |
rofecoxib | butenolide; sulfone | analgesic; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | |
imperatorin | imperatorin : A member of the class of psoralens that is psoralen substituted by a prenyloxy group at position 8. Isolated from Angelica dahurica and Angelica koreana, it acts as a acetylcholinesterase inhibitor. imperatorin: tumor necrosis factor antagonist; furanocoumarin from West African medicinal plant Clausena anisata; structure in Negwer, 5th ed, #3005 | psoralens | EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
truxillic acid | truxillic acid: RN given refers to cpd with unspecified isomeric designation; structure | ||
rac-glycerol 1-monodecanoate | 1-monodecanoylglycerol : A 1-monoglyceride that has decanoyl (capryl) as the acyl group. rac-1-monodecanoylglycerol : A rac-1-monoacylglycerol composed of equal amounts of 3-decanoyl-sn-glycerol and 1-decanoyl-sn-glycerol. rac-glycerol 1-monodecanoate: a monoglyceride of capric acid | rac-1-monoacylglycerol | |
6,7-dichloroquinoline-5,8-dione | 6,7-dichloro-5,8-quinolinedione: structure in first source | ||
nsc 663284 | NSC 663284: structure in first source | quinolone | |
nsc668394 | |||
cocaine | cocaine : A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca. Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. | benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid | adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde: proteasome inhibitor N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal : A tripeptide that is L-leucyl-L-leucyl-L-leucine in which the C-terminal carboxy group has been reduced to the corresponding aldehyde and the N-terminal amino group is protected as its benzyloxycarbonyl derivative. | amino aldehyde; carbamate ester; tripeptide | proteasome inhibitor |
N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide | anilide | ||
cefsulodin | cefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic. Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. | cephalosporin; organosulfonic acid; primary carboxamide | antibacterial drug |
caffeic acid | trans-caffeic acid : The trans-isomer of caffeic acid. | caffeic acid | geroprotector; mouse metabolite |
illudalic acid | illudalic acid: isolated from Clitocybe illudens; structure in first source | ||
linoleic acid | linoleic acid : An octadecadienoic acid in which the two double bonds are at positions 9 and 12 and have Z (cis) stereochemistry. Linoleic Acid: A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed) | octadecadienoic acid; omega-6 fatty acid | algal metabolite; Daphnia galeata metabolite; plant metabolite |
benzyloxycarbonyl-phe-ala-fluormethylketone | cathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1). | ||
HTS 01037 | ring assembly; thiophenes | ||
stigmasterol 3-o-beta-d-glucopyranoside | stigmasterol 3-O-beta-D-glucopyranoside: an antioxidant from Monochoria vaginalis; structure in first source stigmasterol 3-O-beta-D-glucoside : A steroid saponin that is (3beta,22E)-stigmasta-5,22-dien-3-ol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It is isolated from Symplocos lancifolia. | beta-D-glucoside; monosaccharide derivative; phytosterols; steroid saponin | metabolite |
ca 074 | |||
calpain inhibitor iii | calpain inhibitor III: potential anticataract drug | ||
bms 309403 | |||
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid | 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source | ||
rk 682 | |||
variabilin | variabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source |